[Pulmonary hypertension. Major therapeutic advances].
Simonneau
Gérald
G
Hôpital Antoine-Béclère, université Paris-Sud, centre de référence de l'HTAP, département de pneumologie, 92141 Clamart Cedex, France. gerald.simonneau@abc.aphp.fr
D000925:Anticoagulants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D065128:Endothelin Receptor Antagonists; D011464:Epoprostenol / Q000627:therapeutic use; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000628:therapy; D010102:Oxygen Inhalation Therapy; D016896:Treatment Outcome
D000925:Anticoagulants; D000959:Antihypertensive Agents; D002316:Cardiotonic Agents; D004232:Diuretics; D065128:Endothelin Receptor Antagonists; D011464:Epoprostenol